In total, 13 patients across the two cohorts were observed to have rare deleterious SOX17 variants; nine of these had paediatric-onset PAH, suggesting these variants may be enriched in paediatric patients. This evidence concerns the gene SOX17 and pulmonary arterial hypertension.